Patents by Inventor Frank FALTINGER

Frank FALTINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CNP PRODRUGS
    Publication number: 20230116746
    Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.
    Type: Application
    Filed: June 23, 2022
    Publication date: April 13, 2023
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Thomas Wegge, Frank Faltinger, Felix Cleemann, Nora Kaluza, Ana Bernhard, Annette Buba, Tom Woods
  • CONTROLLED-RELEASE CNP AGONISTS WITH LOW NPR-C BINDING
    Publication number: 20220211817
    Abstract: The present invention relates to a controlled-release CNP agonist having low NPR-C affinity; to pharmaceutical compositions comprising said controlled-release CNP agonist; their use; and to methods of treatment.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 7, 2022
    Inventors: Harald Rau, Ulrich Hersel, Kennett Sprogøe, Frank Faltinger, Thomas Wegge, Felix Cleemann
  • Controlled-release CNP agonists with low NPR-C binding
    Patent number: 11311604
    Abstract: The present invention relates to a controlled-release CNP agonist having low NPR-C affinity; to pharmaceutical compositions comprising said controlled-release CNP agonist; their use; and to methods of treatment.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: April 26, 2022
    Assignee: ASCENDIS PHARMA GROWTH DISORDERS A/S
    Inventors: Harald Rau, Ulrich Hersel, Kennett Sprogøe, Frank Faltinger, Thomas Wegge, Felix Cleemann
  • CNP PRODRUGS
    Publication number: 20210069339
    Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.
    Type: Application
    Filed: August 13, 2020
    Publication date: March 11, 2021
    Applicant: ASCENDIS PHARMA GROWTH DISORDERS A/S
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Thomas Wegge, Frank Faltinger, Felix Cleemann, Nora Kaluza, Ana Bernhard, Annette Buba, Tom Woods
  • CNP PRODRUGS
    Publication number: 20190255183
    Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.
    Type: Application
    Filed: February 6, 2019
    Publication date: August 22, 2019
    Applicant: ASCENDIS PHARMA GROWTH DISORDERS A/S
    Inventors: Kennett Sprogøe, Ulrich Hersel, Harald Rau, Thomas Wegge, Frank Faltinger, Felix Cleemann, Nora Kaluza, Ana Bernhard, Annette Buba, Tom Woods
  • CONTROLLED-RELEASE CNP AGONISTS WITH LOW NPR-C BINDING
    Publication number: 20190000926
    Abstract: The present invention relates to a controlled-release CNP agonist having low NPR-C affinity; to pharmaceutical compositions comprising said controlled-release CNP agonist; their use; and to methods of treatment.
    Type: Application
    Filed: January 5, 2017
    Publication date: January 3, 2019
    Inventors: Harald Rau, Ulrich Hersel, Kennett Sprogøe, Frank Faltinger, Thomas Wegge, Felix Cleemann
  • CNP PRODRUGS
    Publication number: 20170368189
    Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.
    Type: Application
    Filed: January 8, 2016
    Publication date: December 28, 2017
    Inventors: Kennett SPROGØE, Ulrich HERSEL, Harald RAU, Thomas WEGGE, Frank FALTINGER, Felix CLEEMANN, Nora KALUZA, Ana BERNHARD, Annette BUBA, Tom WOODS